Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-3059.99%
operating margin TTM
-3084.76%
revenue TTM
73.39 Million
revenue per share TTM
0.84$
valuation ratios | |
|---|---|
| pe ratio | -8.89 |
| peg ratio | -0.50 |
| price to book ratio | 2.98 |
| price to sales ratio | 273.67 |
| enterprise value multiple | -12.22 |
| price fair value | 2.98 |
profitability ratios | |
|---|---|
| gross profit margin | -630.28% |
| operating profit margin | -3084.76% |
| pretax profit margin | -3059.99% |
| net profit margin | -3059.99% |
| return on assets | -31.09% |
| return on equity | -57.61% |
| return on capital employed | -33.55% |
liquidity ratios | |
|---|---|
| current ratio | 14.69 |
| quick ratio | 14.69 |
| cash ratio | 14.53 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 24.04 |
| cash conversion cycle | -24.04 |
| receivables turnover | 0.00 |
| payables turnover | 15.18 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.01 |
| debt equity ratio | 0.01 |
| long term debt to capitalization | 0.01 |
| total debt to capitalization | 0.01 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -49.53 |
cash flow ratios | |
|---|---|
| free cash flow per share | -2.30 |
| cash per share | 7.48 |
| operating cash flow per share | -2.19 |
| free cash flow operating cash flow ratio | 1.05 |
| cash flow coverage ratios | -49.53 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -19.71 |
Frequently Asked Questions
When was the last time Immunome, Inc. (NASDAQ:IMNM) reported earnings?
Immunome, Inc. (IMNM) published its most recent earnings results on 06-11-2025.
What is Immunome, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Immunome, Inc. (NASDAQ:IMNM)'s trailing twelve months ROE is -57.61%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Immunome, Inc. (IMNM) currently has a ROA of -31.09%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did IMNM's net profit margin stand at?
IMNM reported a profit margin of -3059.99% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is IMNM's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 14.69 in the most recent quarter. The quick ratio stood at 14.69, with a Debt/Eq ratio of 0.01.